ENTRY       D00477                      Drug
NAME        Procainamide hydrochloride (JP18/USP);
            Procan SR (TN);
            Procanbid (TN);
            Pronestyl (TN)
PRODUCT
  GENERIC   PROCAINAMIDE HCI (HF Acquisition Co LLC)
            PROCAINAMIDE HCI (HF Acquisition Co LLC)
            PROCAINAMIDE HYDROCHLORIDE (HF Acquisition Co LLC)
            PROCAINAMIDE HYDROCHLORIDE (Hospira)
            PROCAINAMIDE HYDROCHLORIDE (International Medication Systems)
            PROCAINAMIDE HYDROCHLORIDE (Nexus Pharmaceuticals)
FORMULA     C13H21N3O. HCl
EXACT_MASS  271.1451
MOL_WEIGHT  271.7863
CLASS       Cardiovascular agent
             DG01653  Antiarrhythmics
              DG01652  Class I antiarrhythmic agent
               DG01649  Class Ia antiarrhythmic agent
            Metabolizing enzyme substrate
             DG02928  NAT substrate
            Transporter substrate
             DG02858  SLC22A1 substrate
             DG02854  SLC22A2 substrate
             DG02964  SLC47A1 substrate
             DG03002  SLC47A2 substrate
REMARK      Therapeutic category: 2121
            ATC code: C01BA02
            Chemical structure group: DG00193
            Product (DG00193): D00477<JP/US>
EFFICACY    Antiarrhythmic, Sodium channel blocker
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes
            hsa04728(6323)  Dopaminergic synapse
METABOLISM  Enzyme: NAT [HSA:9 10]
            Transporter: SLC22A1 [HSA:6580], SLC22A2 [HSA:6582], SLC47A1 [HSA:55244], SLC47A2 [HSA:146802]
INTERACTION  
STR_MAP     map07028  Antipsychotics
            map07037  Antiarrhythmic drugs
            map07213  Dopamine receptor agonists/antagonists
            map07231  Sodium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01B ANTIARRHYTHMICS, CLASS I AND III
                C01BA Antiarrhythmics, class Ia
                 C01BA02 Procainamide
                  D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               212  Antiarrhythmic agents
                2121  Procainamides
                 D00477  Procainamide hydrochloride (JP18/USP)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01653  Antiarrhythmics
               DG01652  Class I antiarrhythmic agent
                DG01649  Class Ia antiarrhythmic agent
                 DG00193  Procainamide
                  D00477  Procainamide hydrochloride
             Metabolizing enzyme substrate
              DG02928  NAT substrate
               DG00193  Procainamide
                D00477  Procainamide hydrochloride
             Transporter substrate
              DG02858  SLC22A1 substrate
               DG00193  Procainamide
                D00477  Procainamide hydrochloride
              DG02854  SLC22A2 substrate
               DG00193  Procainamide
                D00477  Procainamide hydrochloride
              DG02964  SLC47A1 substrate
               DG00193  Procainamide
                D00477  Procainamide hydrochloride
              DG03002  SLC47A2 substrate
               DG00193  Procainamide
                D00477  Procainamide hydrochloride
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01653  Antiarrhythmics
               D00477  Procainamide hydrochloride
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN2A
                 D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN3A
                 D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN4A
                 D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN5A
                 D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN8A
                 D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN9A
                 D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN10A
                 D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN11A
                 D00477  Procainamide hydrochloride (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00477  Procainamide hydrochloride
              D00477  Procainamide hydrochloride tablets
              D00477  Procainamide hydrochloride injection
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00477
             Drug transporters
              D00477
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00477
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01653  Antiarrhythmics
               DG01652  Class I antiarrhythmic agent
                DG01649  Class Ia antiarrhythmic agent
                 DG00193  Procainamide
             Metabolizing enzyme substrate
              DG02928  NAT substrate
               DG00193  Procainamide
             Transporter substrate
              DG02858  SLC22A1 substrate
               DG00193  Procainamide
              DG02854  SLC22A2 substrate
               DG00193  Procainamide
              DG02964  SLC47A1 substrate
               DG00193  Procainamide
              DG03002  SLC47A2 substrate
               DG00193  Procainamide
DBLINKS     CAS: 614-39-1
            PubChem: 7847543
            ChEBI: 8429
            LigandBox: D00477
            NIKKAJI: J300.505D
ATOM        18
            1   C8y C    18.9171  -15.8141
            2   C5a C    20.1248  -16.5201
            3   C8x C    18.9231  -14.4081
            4   C8x C    17.6921  -16.5084
            5   N1b N    21.3384  -15.8257
            6   O5a O    20.1190  -17.9203
            7   C8x C    17.7154  -13.6964
            8   C8x C    16.4902  -15.7966
            9   C1b C    22.5518  -16.5258
            10  C8y C    16.5018  -14.4022
            11  C1b C    23.7594  -15.8317
            12  N1a N    15.2884  -13.6906
            13  N1c N    24.9728  -16.5318
            14  C1b C    26.1805  -15.8433
            15  C1b C    24.9671  -17.9320
            16  C1a C    27.3941  -16.5375
            17  C1a C    26.1747  -18.6437
            18  X   Cl   30.9992  -17.3018
BOND        17
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     2   6 2
            6     3   7 1
            7     4   8 2
            8     5   9 1
            9     7  10 2
            10    9  11 1
            11   10  12 1
            12   11  13 1
            13   13  14 1
            14   13  15 1
            15   14  16 1
            16   15  17 1
            17    8  10 1
///
